People who receive personalized formulations often report better energy, fewer side effects, and stronger long term adherence
Biologic drugs target specific immune pathways, but patients may still suffer opportunistic infections and longterm risks like cancer
Research-Grade vs Pharma-Grade Peptide Companies: What Is the Difference
421,422,423,424,425 Future directions Future translational arterial stiffness research should (i) enhance clinical assessment (e.g., multimodal imaging, wearable-based PWV analysis in large clinical trials and population studies), (ii) identify specific phenotypes and endotypes, (iii) decipher the underlying mechanisms of the use of state-of-the-art technologies (e.g., specific microfluid cell culture systems, machine learning approaches) and new risk factors (e.g., chronic psychosocial stress, air pollution), and (iv) develop tailored prevention and therapeutic approaches (e.g., new pharmacological agents targeting low-grade systemic inflammation, AI-based personalized intervention)